Welcome Message

Dear [FirstName],

Welcome to the festive issue of Research Roundup. It’s such an exciting time of the year with silly season right around the corner. Hopefully you will all have an opportunity for rest and recouperation over the holidays, before entering the other silly season involving grants, grants and more grants. On that note, Lung Foundation Australia – Better Breathing Foundation are offering a PhD scholarship in chronic lung disease valued at $126,000+GST over 3.5 years, with applications closing this Friday the 17th of December. In addition to this, the Lung Foundation – Boehringer Ingelheim Research Fellowship in Chronic Obstructive Pulmonary Disease valued at $120,000+GST over 2 years, is currently open and will be closing on 14 January 2022. Three LFA research grants are also on offer, each valued at $5,000+GST, with applications closing next Friday the 24th of December. These include:

You will have a bit more time to prepare an application for one of the four Thoracic Society Awards open until the 17th of February. I have the honour of announcing that the overall total amount available for these awards has doubled, enabling greater support for research activities within our society!!! These changes are in response to member feedback from our recent survey and in response to increasing difficulties faced by our research workforce. Available grants include:

There are several grant opportunities also available through the icare Project funding for dust diseases research including discovery grants, translational research grants, focus grants, scholarship and fellowship grants as well as support organisations grants, with all applications closing on the 27th of January. Asthma Australia also have two funding opportunities closing on the 31st of January, one for a 3-year PhD scholarship working in basic and discovery science valued at $135k over three years, and a 2-year fellowship grant in digital health valued at $200k. 

If you're lacking inspiration on what to write for all the upcoming grants, make sure you register for the TSANZSRS Virtual ASM 2022, as this line up promises a wealth of motivation for next wave of innovations and advancements in respiratory medicine. Speaking of excellence in respiratory medicine, huge congratulations to two of our TSANZ members, Professor Christine Jenkins and Professor Ron Grunstein, who have both been elected as Fellows of the Australian Academy of Health and Medical Sciences. They were named among 29 of the nation’s top medical and health researchers elected as Fellows of the Academy. 

If grant writing isn’t your thing, maybe consider contributing to research by participating in one of the surveys currently being undertaken, including a questionnaire on the choice of monoclonal antibody treatments for severe asthma, a survey about factors influencing initiation of invasive long-term ventilation among paediatric populations and a survey about how to improve adherence to smoking cessation medications. Asthma Australia have also put a call out for peer reviewers interested in joining their research panel and the Australian Commission on Safety and Quality in Health Care are seeking feedback on requirements for a national health and human research platform – the National One Stop Shop. Finally, there are also some great podcasts and reads via The Limbic, Respiratory Research Review and TBPod in this edition. 

As always, wishing you all happy researching and happy holidays. 

A/Prof Kristin Carson-Chahhoud

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Indigenous Respiratory Nurses Development Award – closing 17 February 2021

TSANZ Past President Scholarship Award – closing 17 February 2021

TSANZ Peter Phelan Paediatric Research Grant – closing 17 February 2021

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closing 17 February 2021

Lung Foundation Australia Awards

Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease – closes 17 December 2021

Lung Foundation Australia – Ivan Cash Research Grant in Pulmonary Fibrosis – closes 24 December 2021

Lung Foundation Australia – Lizotte Family Research Grant in Pulmonary Fibrosis – closes 24 December 2021

Lung Foundation Australia – Ludwig Engel Research Grant in Respiratory Research – closes 24 December 2021

Lung Foundation Australia – Boehringer Ingelheim Research Fellowship in Chronic Obstructive Pulmonary Disease (COPD) – closes 14 January 2022

        

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZSRS VIRTUAL ASM 2022

 

Don’t forget to submit your abstract!

 

***Can this be a don't forget to register thing instead now?***

As you may be aware, the TSANZSRS ASM 2022 will now be a virtual meeting. The committee is planning a vibrant and engaging program...
 

Please click here to access the conference website for more information!

icare Project funding for dust diseases research and support

The Dust Diseases Board is comprised of 10 independent members across a range of scientific, medical, advocacy and peak bodies in the dust diseases industry. 

Through funding research, the Dust Diseases Board aims to reduce the risk of people developing dust diseases and to optimise health and care outcomes for people with a dust disease and their families. They also support building research capacity in dust diseases research to ensure ongoing pursuit of excellence in research in relevant fields through funding for scholarships and fellowships.

The Dust Diseases Board convenes quarterly to discuss and assess its grants programs.

The Dust Diseases Board has developed the following grant funding streams to help deliver a range of positive outcomes to workers affected by dust diseases:

  • Ideas to Action Grants: Discovery Grants and Translational Research Grants
  • Focus Grants
  • Scholarships and Fellowships Grant Program
  • Support Organisations Grants. 

Please click here for the grant programs application guidelines and the application forms for the discovery grants, translational Research grants and the Focus grants.

For more information, please contact our Research and Education unit via email ddcgrants@icare.nsw.gov.au.

All grants applications close on 27 January 2022.

Asthma Australia Research Funding Opportunity

Asthma Australia is dedicated to contributing to vital asthma research to help people with asthma live freely, as well as promoting and encouraging emerging researchers in the field.

We are excited to announce the opportunity for researchers and research groups in Australia to apply for two new funding opportunities.

Applications are now open for:
• 3-year PhD group scholarship in basic and discovery science 
• 2-year fellowship grant investigating and advancing the role of digital health strategies for the benefit of people with asthma

Applications close 31st January 2020.

Learn More

We look forward to hearing from you, 
Anthony Flynn
Research, Information and Evaluation Manager

TSANZ Members are elected as Fellows of the Australian Academy of Health and Medical Sciences

The Australian Academy of Health and Medical Sciences (AAHMS) has welcomed this year’s newly elected Fellows, recognising the brightest minds in health and medical sciences across a range of fields, including research, industry and more.

The TSANZ offer their congratulations to TSANZ members - Professor Christine Jenkins and Professor Ron Grunstein who are among 29 of the nation’s top medical and health researchers elected as Fellows of the Academy. 

 

Professor Jenkins, head of the Respiratory Group at the George Institute for Global Health is recognised for her extensive contribution to the profession and substantially raised public understanding of health and medical science, having previously served as TSANZ President, and currently Chairing the Board of Lung Foundation Australia.

 

Professor Ron Grunstein, head of Sleep and Circadian Research Group at the Woolcock Institute of Medical Research is elected to the Academy in recognition of his role as the leading sleep medicine clinician-researcher in Australia and one of the world leaders in this discipline. Ron's work has made sleep and wakefulness safer for all Australians.

 

Please click here for more information on AAHMS's newly elected Fellows and their exceptional contributions!

 

Asthma Australia Peer Review Research Panel

Expression of Interest – Peer Review Research Panel

At Asthma Australia we are proud to fund research through our National Asthma Research Program. Through our funding we have been able to directly contribute to some of the most impactful changes worldwide in asthma knowledge and treatment and support emerging researchers in the field.

We are committed to investing in progressive approaches to make, translate and implement new discoveries that improve the lives of people with asthma. You can read more about our research program strategy here.

To support the delivery of our research program, we are looking for experienced researchers to take part in our Peer Review Panel.

This is an opportunity to contribute to asthma research in Australia and an exciting leadership opportunity. You will have the opportunity to familiarise yourself with the breadth of asthma research happening in Australia, contribute to Asthma Australia’s research vision, and expose yourself to grant writing examples to improve your own applications.

What is involved?  

If you join the peer review panel, you will receive requests to review applications on a periodic basis.

You can choose when to be involved and would be asked to review up to 5 applications at any one time (depending on number of applications received and number of available reviewers).

Register your interest

If you have any questions or would like to be involved in Asthma Australia’s Peer Review Panel, please email Rose Bell (Research and Evaluation Coordinator) rbell@asthma.org.au.

An online induction will be organised for the new year.

Respirology - Editor's Choice

 

Respirology Issue 26.12 December 2021

Air pollution and the pandemic: Long-term PM2.5 exposure and disease severity in COVID-19 patients

Angelico Mendy, Xiao Wu, Jason L. Keller, Cecily S. Fassler, Senu Apewokin, Tesfaye B. Mersha, Changchun Xie, Susan M. Pinney

DOI: 10.1111/resp.14140

Surveys and Research

ISAR COLLABORATOR SURVEY: MONOCLONAL ANTIBODY TREATMENT DECISIONS FOR SEVERE ASTHMA

Asthma specialists are invited to complete a questionnaire on the choice of monoclonal antibody treatments in severe asthma. The research is being undertaken by Dr. Andreanne Côté’s asthma research team from Quebec City (Canada) and is a collaboration with the International Severe Asthma Registry (ISAR).

The aim of this study is to compare the choice of biological treatment by different medical specialists treating patients with severe asthma, on the basis of real clinical cases.

Your participation will consist of completing an online questionnaire anonymously. The questionnaire has 2 sections:

  1. a short section to collect some information about your practice in order to characterize the participants and
  2. 7 case stories followed by questions about the treatment decision

The questionnaire is completely anonymous and is estimated that a maximum of 30 minutes will be needed to complete it. 

It can easily be filled on any electronic device. You can open the questionnaire in your web browser by clicking the link below: 

https://collaboration.criucpq.ulaval.ca/redcap/surveys/?s=KHHRC9ETND

If the link above doesn't work, try copying and pasting it into your web browser: 'https://collaboration.criucpq.ulaval.ca/redcap/surveys/?s=KHHRC9ETND'

To thank you for your participation, you will be acknowledged as a collaborator in any publication that may result from this study. After completing the survey, you will be directed to a separate page to provide your personal information, which will not be linked to your answers.

The study was approved by the Research Ethics Committee of the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (CÉR22078). All data collected will be processed anonymously. The Biological Choice Study Team, Principal Investigator: Dre Andréanne Côté

For any questions or comments, contact: etude.choixbiologique@criucpq.ulaval.ca

The survey closes on 20th December 2021.

 

TECHCHILD RESEARCH STUDY

We are writing to ask for your help in an international study exploring the factors that influence the initiation of invasive long-term ventilation (LTV) as an example of technology dependence.  We are asking all paediatric clinical professionals (e.g. medical doctors, nurses, physiotherapists, dieticians, pharmacists, respiratory therapists and other MDTs) with experience of working with children initiated on LTV to participate. This study is important as it aims to identify the greatest influences on the initiation of invasive LTV and to explore the meaning of this in the context of contrasting health, legal, economic and political systems.

A review of the literature and analysis of interviews with multi-professional clinicians working with children on LTV internationally, suggests several factors that may influence the initiation of invasive LTV. The scenarios provided in this survey aim to explore these factors further.

We request you respond as an individual (i.e. not at an institutional level). Participation is voluntary and if you chose to take part your answers will be completely confidential and you will not be identified from this questionnaire. Your views on this topic would be very helpful and by responding you will increase the accuracy of the survey results. Completion of the questionnaire should take approximately 10-15 minutes.

If you choose to click on the link/scan the QR code below you will be brought to the survey which will include an introduction, downloadable participation information leaflet and consent form followed by the survey.

https://nursingandmidwifery.fra1.qualtrics.com/jfe/form/SV_4M9P0vCkqqeUkXs

We really appreciate your interest in this study. If you have any questions about your participation, please contact Prof Maria Brenner (PI) at brennerm@tcd.ie or our TechChild Project Manager, Dr. Mary Quirke at quirkemb@tcd.ie We would also be very grateful if you could forward this email to colleagues who might also be interested in taking part.

Yours sincerely,

Prof Maria Brenner
Professor in Children’s Nursing
Head of Discipline for Children's Nursing
School of Nursing and Midwifery,
Trinity College Dublin, the University of Dublin,
24 D’Olier Street,
Dublin,Ireland.
+35318963901                                      
brennerm@tcd.ie 

 

ATTITUDE AND PRACTICE OF HEALTH CARE PROVIDERS TOWARDS IMPROVING ADHERENCE TO SMOKING CESSATION MEDICATIONS

We recently conducted a systematic review that showed that only one in four smokers use NRT as instructed by the health professionals.  

We are conducting a 10-minute online survey among to identify the factors from the health professionals’ perspective.  

The study is approved by the University of Newcastle Human Research Ethics Committee, Approval H-2020-0334.   

Participants will enter a draw to award 4 individuals with $300 gift vouchers each. 

The survey can be accessed by clicking HERE.

We appreciate the support.

Amanual Getnet Mersha
School of Medicine and Public Health
The University of Newcastle
AmanualGetnet.Mersha@uon.edu.au

 

AUSTRALIAN COMMISSION ON SAFETY AND QUALITY IN HEALTH CARE
NATIONAL ONE STOP SHOP

Have your say on national health and human research platform

You are invited to share feedback on the requirements for a national health and human research platform – the National One Stop Shop.

The aim of the National One Stop Shop is to make it easier for patients, researchers, industry representatives and sponsors to find, conduct, participate and invest in high quality and ethical research in Australia.

Stakeholders working in the health and human research sector can provide feedback via the national survey or directly to the Health and Medical Research Team.

The Commission is inviting submissions and participation until 17 December 2021.

Consumer survey now open

We are also exploring options for building awareness of research participation and have launched a consumer survey for people to have their say.

People from across the community are encouraged to complete the consumer survey. Your experiences and insights will help inform our understanding of community expectations for research participation.

Please share these surveys with your colleagues, patients and people in your network, to help us obtain valuable insights that will help shape the new national platform.

Find out more on our web page, or contact our Health and Medical Research team at HMR@safetyandquality.gov.au if you have questions.

 

EXPRESSION OF INTEREST – PEER REVIEW RESEARCH PANEL

At Asthma Australia we are proud to fund research through our National Asthma Research Program. Through our funding we have been able to directly contribute to some of the most impactful changes worldwide in asthma knowledge and treatment and support emerging researchers in the field.

We are committed to investing in progressive approaches to make, translate and implement new discoveries that improve the lives of people with asthma. You can read more about our research program strategy here.

To support the delivery of our research program, we are looking for experienced researchers to take part in our Peer Review Panel.

This is an opportunity to contribute to asthma research in Australia and an exciting leadership opportunity. You will have the opportunity to familiarise yourself with the breadth of asthma research happening in Australia, contribute to Asthma Australia’s research vision, and expose yourself to grant writing examples to improve your own applications.

What is involved?  

If you join the peer review panel, you will receive requests to review applications on a periodic basis.

You can choose when to be involved and would be asked to review up to 5 applications at any one time (depending on number of applications received and number of available reviewers).

Register your interest

If you have any questions or would like to be involved in Asthma Australia’s Peer Review Panel, please email Rose Bell (Research and Evaluation Coordinator) rbell@asthma.org.au.

An online induction will be organised for the new year.

 

TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

This study has now been completed and below is a summary of the findings from this work.

The top 3 priorities rank by people with PF and caregivers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. What medications can improve lung function in people with PF?
  3. What are the causes of PF?

The top 3 priorities rank by people with healthcare professionals/researchers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. How can we prevent PF?
  3. What are the causes of PF?

The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

 (click on the link to view the paper-- https://doi.org/10.1136/thoraxjnl-2020-215731)

The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

Yours sincerely,

Anne Holland
Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.